FBN1 and colorectal carcinoma: The result showed that methylated FBN1 was detected in 77.5% (69/89) of CRC tissue samples and 70.8% (63/89) of stool samples, which was similar to our pervious study (CRC tissue samples: 78.7%; CRC stool samples: 72%).